XRAY logo

DENTSPLY SIRONA Inc. (XRAY)

$11.57

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on XRAY

Market cap

$2.31B

EPS

-4.35

P/E ratio

--

Price to sales

0.64

Dividend yield

5.532%

Beta

1.010951

Price on XRAY

Previous close

$11.60

Today's open

$11.59

Day's range

$11.54 - $11.79

52 week range

$9.85 - $20.60

Profile about XRAY

CEO

Simon D. Campion

Employees

14000

Headquarters

Charlotte, NC

Exchange

Nasdaq Global Select

Shares outstanding

199551969

Issue type

Common Stock

XRAY industries and sectors

Healthcare

Medical Equipment & Supplies

News on XRAY

3 Healthcare Stocks Topping a 2025 List of Dividend Yields

Bristol Myers Squibb has a high dividend yield, is very cheap, and may have better growth prospects than it might seem at first glance. Pfizer now has a 7% yield, and may have found a solution to its patent cliff issue.

news source

The Motley Fool • Nov 13, 2025

news preview

New Strong Sell Stocks for Nov. 11

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

news source

Zacks Investment Research • Nov 11, 2025

news preview

Brickwood Asset Management Adds $19 Million in Dentsply Sirona (NASDAQ: XRAY) Shares: Should Investors Buy the Turnaround Stock?

Brickwood added 1,496,935 shares of XRAY, raising position value by $19.03 million. The transaction represented 15.2% of Brickwood's 13F reportable assets under management.

news source

The Motley Fool • Nov 10, 2025

news preview

Unlocking Dentsply (XRAY) International Revenues: Trends, Surprises, and Prospects

Explore how Dentsply's (XRAY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

news source

Zacks Investment Research • Nov 10, 2025

news preview

Dentsply Sirona Stock Sinks On Missed Expectations, Lowered 2025 Guidance; CEO Unveils Return-To-Growth Plan

Dentsply Sirona Inc. (NASDAQ:XRAY) stock is trading lower on Thursday after weaker-than-expected third-quarter earnings and lowered guidance.

news source

Benzinga • Nov 6, 2025

news preview

DENTSPLY SIRONA Inc. (XRAY) Q3 2025 Earnings Call Transcript

DENTSPLY SIRONA Inc. ( XRAY ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Wade Moody Daniel Scavilla - President, CEO & Director Conference Call Participants Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division David Saxon - Needham & Company, LLC, Research Division Jordan Bernstein - Stifel, Nicolaus & Company, Incorporated, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Erin Wilson Wright - Morgan Stanley, Research Division Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Ahmed Muhammad Rahat - Leerink Partners LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division Allen Lutz - BofA Securities, Research Division Brandon Vazquez - William Blair & Company L.L.C.

news source

Seeking Alpha • Nov 6, 2025

news preview

Dentsply Sirona Reports Third Quarter 2025 Results

CHARLOTTE, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2025 and introduced its Return-to-Growth action plan, a comprehensive strategy to improve performance and position the Company for sustained, profitable growth over the next 24 months.

news source

GlobeNewsWire • Nov 6, 2025

news preview

Dentsply International (XRAY) Lags Q3 Earnings Estimates

Dentsply International (XRAY) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.5 per share a year ago.

news source

Zacks Investment Research • Nov 6, 2025

news preview

Compared to Estimates, Dentsply (XRAY) Q3 Earnings: A Look at Key Metrics

The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

news source

Zacks Investment Research • Nov 6, 2025

news preview

XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View

DENTSPLY SIRONA shares drop as Q3 earnings miss estimates and 2025 EPS guidance is cut amid segment weakness.

news source

Zacks Investment Research • Nov 6, 2025

news preview

¹ Disclosures

Get started with M1

Invest in DENTSPLY SIRONA Inc.

Open an M1 investment account to buy and sell DENTSPLY SIRONA Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in XRAY on M1